Activated prothrombin complex concentrate for reversal of oral factor Xa inhibitors at a level 1 trauma center

被引：1
|
作者：
Bobby, Lauren [1 ]
Westlake, Evan [1 ]
Esplin, Nathan [2 ]
Young, Sarah [1 ]
机构：
[1] Allegheny Gen Hosp, Dept Pharm, 320 North Ave, Pittsburgh, PA 15212 USA
[2] Allegheny Gen Hosp, Dept Neurosurg, 320 North Ave, Pittsburgh, PA 15212 USA
来源：
THROMBOSIS RESEARCH | 2021年 / 206卷
关键词：
Apixaban; Rivaroxaban; Reversal; Activated prothrombin complex concentrate (aPCC); Intracranial hemorrhage (ICH); Andexanet alfa; ANTICOAGULANTS; MANAGEMENT; OUTCOMES; FEIBA;
D O I：
10.1016/j.thromres.2021.08.005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：33 / 35
页数：3
相关论文
共 50 条
  • [31] More efficient reversal of dabigatran inhibition of coagulation by activated prothrombin complex concentrate or recombinant factor VIIa than by four-factor prothrombin complex concentrate
    Lindahl, Tomas L.
    Wallstedt, Maria
    Gustafsson, Kerstin M.
    Persson, Egon
    Hillarp, Andreas
    THROMBOSIS RESEARCH, 2015, 135 (03) : 544 - 547
  • [32] Reversing direct factor Xa or thrombin inhibitors: Factor V addition to prothrombin complex concentrate is beneficial in vitro
    Brinkman, Herm Jan M.
    Swieringa, Frauke
    Zuurveld, Marleen
    Veninga, Alicia
    Brouns, Sanne L. N.
    Heemskerk, Johan W. M.
    Meijers, Joost C. M.
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2022, 6 (03)
  • [33] Retrospective Comparison of Andexanet Alfa and 4-Factor Prothrombin Complex for Reversal of Factor Xa-Inhibitor Related Bleeding
    Stevens, Victoria M.
    Trujillo, Toby C.
    Kiser, Tyree H.
    MacLaren, Robert
    Reynolds, Paul M.
    Mueller, Scott W.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2021, 27
  • [34] Incidence of thromboembolic events following administration of four-factor prothrombin complex concentrate (4F-PCC) for oral anticoagulation reversal
    Makhoul, Therese
    Kelly, Gregory
    Kersten, Brian
    Nadler, Megan
    Zammit, Christopher G.
    Jones, Courtney M. C.
    Scott, Rachael
    Acquisto, Nicole M.
    THROMBOSIS RESEARCH, 2020, 194 : 158 - 164
  • [35] Prothrombin complex concentrate for direct factor Xa inhibitor-associated bleeding or before urgent surgery
    Shaw, Joseph R.
    Almujalli, Abdulrahman Abdulaziz
    Xu, Yan
    Levy, Jerrold H.
    Schulman, Sam
    Siegal, Deborah
    Dowlatshahi, Dar
    Tokessy, Melanie
    Buyukdere, Hakan
    Carrier, Marc
    Castellucci, Lana A.
    THROMBOSIS RESEARCH, 2024, 243
  • [36] Fixed vs Weight-Based Dosing of Four-Factor Prothrombin Complex Concentrate for Factor Xa Inhibitor Reversal in Patients With a Non-Neurologic Hemorrhage
    Stokes, Tyson
    Johnson, Christopher
    Fish, Tyler
    Mishler, Aimee
    JOURNAL OF PHARMACY PRACTICE, 2025,
  • [37] Andexanet Alfa versus Four-Factor Prothrombin Complex Concentrate for the Reversal of Factor Xa (FXa) Inhibitor-Associated Intracranial Hemorrhage: A Systematic Review of Retrospective Studies
    Ferreira, Luan Oliveira
    Oldemburg, Ricardo Andres Leon
    Leitao Filho, Joao Monteiro
    Cerveira, Rodrigo Arcoverde
    Vasconcelos, Victoria Winkler
    da Costa, Giovana Escribano
    Rodrigues, Roseny dos Reis
    Lopes, Dielly Catrina Favacho
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (11)
  • [38] Evaluation of the Use of Low-Dose 4-Factor Prothrombin Complex Concentrate in the Reversal of Direct Oral Anticoagulants in Bleeding Patients
    Allison, Teresa A.
    Lin, Pei Jen
    Gass, Jennifer A.
    Chong, Kenneth
    Prater, Samuel J.
    Escobar, Miguel A.
    Hartman, Heather D.
    JOURNAL OF INTENSIVE CARE MEDICINE, 2020, 35 (09) : 903 - 908
  • [39] High-dose versus low-dose 4-factor prothrombin complex concentrate for factor Xa inhibitor reversal in intracranial hemorrhage
    Davis, Spencer D.
    Chauv, Stephanie
    Hickman, Abby W.
    Collingridge, Dave S.
    Kjerengtroen, Sara
    Fontaine, Gabriel, V
    THROMBOSIS RESEARCH, 2021, 208 : 112 - 116
  • [40] Efficacy of prothrombin complex concentrate in the management of oral factor Xa inhibitors associated major bleed assessed by ISTH and ANNEXA-4 criteria
    Dev, Pallavi
    Abousaab, Carol
    Zhou, Cecilia
    Sarode, Ravi
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022, 53 (02) : 249 - 256
12345